ProfileGDS4132 / 240495_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 39% 34% 42% 44% 41% 39% 38% 39% 40% 43% 43% 44% 37% 39% 45% 49% 44% 32% 41% 43% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101102.15739
GSM201543Muscle PCOS pioglitazone 12176.658434
GSM201544Muscle PCOS pioglitazone 161112.41742
GSM201545Muscle PCOS pioglitazone 201124.13244
GSM201829Muscle PCOS pioglitazone 231114.78741
GSM201830Muscle PCOS pioglitazon 251105.4939
GSM201831Muscle PCOS pioglitazone 27198.154338
GSM201832Muscle PCOS pioglitazone 31100.38139
GSM201833Muscle PCOS pioglitazone 4196.80940
GSM201834Muscle PCOS pioglitazone 81109.73143
GSM201835Muscle PCOS after pioglitazone 10298.718343
GSM201836Muscle PCOS after pioglitazone 122103.07244
GSM201837Muscle PCOS after pioglitazone 16278.215837
GSM201838Muscle PCOS after pioglitazone 20290.184239
GSM201839Muscle PCOS after pioglitazone 232111.49145
GSM201840Muscle PCOS after pioglitazone 252127.90349
GSM201841Muscle PCOS after pioglitazone 27299.264344
GSM201842Muscle PCOS after pioglitazone 3263.416532
GSM201843Muscle PCOS after pioglitazone 42101.54841
GSM201844Muscle PCOS after pioglitazone 82106.9843